In the fight against drug-resistant infections, new antibiotics are emerging as a beacon of hope for the future of medicine.Kinvard Bio, a dynamic startup founded by influential researchers from Harvard University, is pioneering a groundbreaking class of antibiotics designed to combat the alarming rise of antibiotic resistance.